CNS establishes US operations
09 January, 2015 by Dylan Bushell-EmblingConsulting company Clinical Network Services (CNS) has established an office in the US to allow it to support clients seeking to engage with the FDA.
Graeme Clark wins Russ Prize for cochlear implant
08 January, 2015 by Dylan Bushell-EmblingProfessor Graeme Clark and four international scientists have jointly won the biennial US$500,000 Russ Prize for their contributions to the developing the cochlear implant.
Inaugural industry report released
11 December, 2014The Australian Industry Report 2014 has been released by the Department of Industry's Office of the Chief Economist. Providing an overview and analysis of the major economic factors affecting Australia's industries, the focus of this year's inaugural report is structural change.
AusBiotech reflects on a year of advocacy and achievement
11 December, 2014For the biotechnology industry and for AusBiotech, the past year has been another action-packed period in policy terms, as well as the year the Australian biotech industry was ranked fourth in the world.
Join the Australian pavilion at the China Medical Equipment Fair
09 December, 2014AusBiotech seeks your expression of interest to join the Australian delegation to the 73rd China International Medical Equipment Fair (CMEF) in May 2015. It is said to be the Asia-Pacific's largest exhibition, with around 2700 exhibitors and 80,000 visitors.
GI Dynamics to cut 10% of jobs
09 December, 2014 by Dylan Bushell-EmblingGI Dynamics (ASX:GID) has revealed a restructuring plan involving cutting 10% of its workforce, including CFO Robert Crane.
Cochlear appoints two new directors
09 December, 2014 by Dylan Bushell-EmblingCochlear has announced that seasoned executives Alison Deans and Glen Boreham will take on non-executive director roles starting from next year.
Orthocell enters bone repair partnership
08 December, 2014 by Dylan Bushell-EmblingOrthocell (ASX:OCC) has signed a deal to develop bone repair products combining technology from the company and from Bonesupport.
Phosphagenics gets ethics nod for its pain patch trial
08 December, 2014 by Dylan Bushell-EmblingPhosphagenics (ASX:POH) has won ethics approval for a proof-of-concept phase II trial of its TPM/Oxycodone patch in neuropathic pain.
Launch of VivaGel condoms delayed in Japan
05 December, 2014 by Dylan Bushell-EmblingStarpharma (ASX:SPL) and partner Okamoto Industries have had to delay the launch of their VivaGel condoms in Japan for at least 3-6 months pending a regulatory classification review.
Project aims to improve pharma manufacturing efficiency
05 December, 2014 by Dylan Bushell-EmblingCSL (ASX:CSL), Hospira and GlaxoSmithKline have partnered with META and the University of Melbourne for a project aimed at improving manufacturing efficiency at Australian sites.
Boosting commercial returns from research
04 December, 2014AusBiotech has made a submission to the federal government's consultation regarding 'Boosting commercial returns from research', as part of the Industry Innovation and Competitiveness Agenda.
Rhinomed's Mute approved by TGA, FDA, EMA
04 December, 2014 by Dylan Bushell-EmblingRhinomed (ASX:RNO) has won approval from key regulators for Mute, a medical device for snoring and sleep breathing, and published top-line data from a trial of the product in snorers.
VivaGel condoms cleared for sale in NZ: Starpharma
02 December, 2014 by Dylan Bushell-EmblingStarpharma and partner Ansell have won regulatory approval to market the LifeStyles Dual Protect condoms in New Zealand.
Let the partnering begin! Biotech investment takes centre stage at Australia Biotech Invest 2014
02 December, 2014Two days of intensive discussion at Australia Biotech Invest 2014 will commence tomorrow to highlight the innovation and positive momentum happening in the Australian life sciences sector.
